{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:50:20Z","timestamp":1760122220631},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.intimp.2012.10.029","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T21:30:28Z","timestamp":1353360628000},"page":"97-105","source":"Crossref","is-referenced-by-count":8,"title":["Multiple antigen peptide consisting of B- and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice"],"prefix":"10.1016","volume":"15","author":[{"given":"Riyasat","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raza Ali","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishfaq Ahmed","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.N.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2012.10.029_bb0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis-etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.intimp.2012.10.029_bb0010","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2012.10.029_bb0015","first-page":"653","article-title":"Effectiveness of live or killed plague vaccines in man","volume":"42","author":"Meyer","year":"1970","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.intimp.2012.10.029_bb0020","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.70.3.1453-1460.2002","article-title":"Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis","volume":"70","author":"Du","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2012.10.029_bb0025","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/IAI.64.6.2180-2187.1996","article-title":"Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge","volume":"64","author":"Andrews","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2012.10.029_bb0185","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1093\/infdis\/129.Supplement_1.S41","article-title":"Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis","volume":"129","author":"Meyer","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.intimp.2012.10.029_bb0035","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0021-9258(19)77935-6","article-title":"A novel method for producing antipeptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain","volume":"263","author":"Posnett","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2012.10.029_bb0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1925584","article-title":"Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen","volume":"254","author":"Wang","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.intimp.2012.10.029_bb0045","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.4049\/jimmunol.160.4.2000","article-title":"HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160","volume":"160","author":"VanCott","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.10.029_bb0050","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/S0264-410X(01)00163-3","article-title":"Vaccination against bubonic and pneumonic plague","volume":"19","author":"Titball","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2012.10.029_bb0055","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1016\/j.vaccine.2010.09.062","article-title":"Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V)","volume":"28","author":"Patricia","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2012.10.029_bb0060","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0928-8244(03)00170-6","article-title":"Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles","volume":"38","author":"Sabhnani","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.intimp.2012.10.029_bb0065","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-3083.2009.02365.x","article-title":"Cell-mediated immune response and Th1\/Th2 cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis","volume":"71","author":"Gupta","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.intimp.2012.10.029_bb0070","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1016\/j.vaccine.2006.01.031","article-title":"Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery","volume":"24","author":"Tripathi","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2012.10.029_bb0075","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1002\/eji.1830221030","article-title":"The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides","volume":"22","author":"Partidos","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2012.10.029_bb0080","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.85.15.5409","article-title":"Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system","volume":"85","author":"Tam","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2012.10.029_bb0085","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.1016\/j.vaccine.2011.09.129","article-title":"Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice","volume":"29","author":"Uppada","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2012.10.029_bb0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.vaccine.2007.11.028","article-title":"Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis","volume":"26","author":"Khan","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2012.10.029_bb0095","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/IAI.74.5.3068-3070.2006","article-title":"Administration of antibody to the lung protects mice against pneumonic plague","volume":"74","author":"Hill","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2012.10.029_bb0100","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1016\/j.vaccine.2005.12.016","article-title":"Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine","volume":"24","author":"Elvin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2012.10.029_bb0105","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.1998.58.793","article-title":"Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice","volume":"58","author":"Anderson","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.intimp.2012.10.029_bb0110","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2012.10.029_bb0115","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/IAI.64.11.4580-4585.1996","article-title":"Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis","volume":"64","author":"Anderson","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2012.10.029_bb0120","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.4049\/jimmunol.161.9.4463","article-title":"CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice","volume":"161","author":"McCluskie","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.10.029_bb0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2012.10.029_bb0130","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2003.12.020","article-title":"CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques","volume":"22","author":"Klinman","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2012.10.029_bb0135","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.intimp.2009.06.008","article-title":"Induction of mucosal and systemic humoral immune responses in murine system byintranasal immunization with peptide antigens of P. vivax and CpG oligodeoxynucleotide (ODN) in microparticle delivery","volume":"9","author":"Bhat","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2012.10.029_bb0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2012.10.029_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cellimm.2012.07.002","article-title":"Cell-mediated immune response to epitopic MAP (Multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model","volume":"278","author":"Rupesh","year":"2012","journal-title":"Cell Immunol"},{"key":"10.1016\/j.intimp.2012.10.029_bb0150","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.4049\/jimmunol.174.10.6518","article-title":"Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release","volume":"174","author":"Mihai","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.10.029_bb0155","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1074\/jbc.C200651200","article-title":"Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection","volume":"278","author":"Girardin","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2012.10.029_bb0160","first-page":"545","article-title":"Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis","volume":"118","author":"Watanabe","year":"2008","journal-title":"J Clin Invest"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2012.10.029_bb0190","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/mi.2008.42","article-title":"The molecular basis of NOD2 susceptibility mutations in Crohn's disease","volume":"1","author":"Stober","year":"2008","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.intimp.2012.10.029_bb0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.0105-2896.2005.00278.x","article-title":"The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces","volume":"206","author":"Kaetzel","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.intimp.2012.10.029_bb0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0264-410X(92)90021-B","article-title":"The mucosal immune system: from fundamental concepts to vaccine development","volume":"10","author":"McGhee","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2012.10.029_bb0180","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.1073\/pnas.86.23.9084","article-title":"Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes","volume":"86","author":"Tam","year":"1989","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912003268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912003268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T21:42:09Z","timestamp":1687815729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576912003268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1567576912003268"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2012.10.029","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}